Old Web
English
Sign In
Acemap
>
authorDetail
>
Malcolm Light
Malcolm Light
Tulane University
Abiraterone acetate
Prostate cancer
Medicine
Positron emission tomography
castration resistant
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
PD-L1 inhibition with avelumab plus abiraterone acetate or enzalutamide in African Americans with metastatic castrate-resistant prostate cancer (mCRPC).
2021
Journal of Clinical Oncology
Jodi Lyn Layton
Charlotte Manogue
Malcolm Light
Ellen Jaeger
Patrick Cotogno
Elisa Ledet
Brian E. Lewis
Pedro C. Barata
A. Oliver Sartor
Show All
Source
Cite
Save
Citations (0)
18F-fluciclovine positron emission tomography (PET) in metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone acetate.
2021
Journal of Clinical Oncology
Pedro C. Barata
Charlotte Manogue
Ellen Jaeger
Malcolm Light
Patrick Cotogno
Elisa Ledet
Janeiro Valle Goffin
Jodi Lyn Layton
Brian E. Lewis
A. Oliver Sartor
Show All
Source
Cite
Save
Citations (0)
1